NCT04470869

Brief Summary

The investigators thought that the confinement measure took in France could induce an increase in the post traumatic syndrome in the relative of patient hospitalized in ICU during this period indeed the restricted visit and the limited interaction with ICU team are documented risk factors for PTSD in this population. The investigators designed an intervention in order to prevent the effect of the confinement measures on PTSD in relatives named OLAF. In this research the investigators aimed to study the impact on this intervention on PTSD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
129

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2020

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

July 3, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 14, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2021

Completed
Last Updated

June 1, 2022

Status Verified

May 1, 2022

Enrollment Period

1.3 years

First QC Date

July 3, 2020

Last Update Submit

May 30, 2022

Conditions

Keywords

intensive care unitconfinementSARS-CoV-2post-traumatic stress disorder

Outcome Measures

Primary Outcomes (1)

  • incidence of PTSD observed 6 months after patient's discharge from the intensive care unit

    To demonstrate the benefits of a comprehensive family approach (OLAF) on the incidence of PTSD observed in 2 close referents of a patient, 6 months after leaving the intensive care unit, in the context of confinement linked to the SARS pandemic- CoV2.

    Month 6

Secondary Outcomes (9)

  • incidence of PTSD observed 6 months after patient's death in the intensive care unit

    Month 6

  • PTSD incidence at month 3

    Month 3

  • PTSD incidence at month 12

    Month 12

  • Symptoms incidence at month 3

    Month 3

  • Symptoms incidence at month 6

    Month 6

  • +4 more secondary outcomes

Study Arms (2)

OLAF group

EXPERIMENTAL

The interventional group (OLAF) benefit from a psychiatric follow up, from virtual visiting of the patient and video interview with ICU team.

Other: Phone call

Control

PLACEBO COMPARATOR

The control group contains the relatives of patients hospitalized after the confinement measure but before the OLAF intervention. This group benefit from phone contact with the ICU team at the admission in ICU then two contact per week minimum to one contact per day maximum during the stay, excepting the specific phone calls associated with favorable or unfavorable evolution.

Other: Phone call

Interventions

The relatives of both groups will be contacted by phone one month after the discharge of the ICU of the death, three month after, six month after and twelve month after. During these interviews the PTSD symptoms, the anxiety and depression symptoms, the complicated grief symptoms (in case of death) and the satisfaction about the ICU stay will be collected.

ControlOLAF group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Contact person (defined as the person that bring a support to the patient et with who the patient had close relationship) aged from more than 18 years old of a patient hospitalized during the confinement and the restricted visited during the SARS-CoV2 pandemic. Two contact persons maximum will be included by patient.
  • Affiliated to the social security
  • Agreed to participated by oral consent

You may not qualify if:

  • Physical visits permitted by the end of the confinement
  • Language barrier
  • Sensorial handicap (blindness or deafness) compromising the comprehension of the information
  • Legal protection of adults
  • Refusal of participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Toulouse

Toulouse, Occitanie, 31000, France

Location

Related Publications (1)

  • Raymond V, Aitout C, Ducos G, Coullomb A, Ferre F, Vardon-Bounes F, Riu-Poulenc B, Seguin T, Boukhatem L, Geeraerts T, Minville V, Fourcade O, Birmes P, Arbus C, Silva S, Salles J. Effectiveness of psychiatric support for PTSD among a cohort of relatives of patients hospitalized in an intensive care unit during the French COVID-19 lockdown-The OLAF (Operation Liaison et Aide aux Familles): A quasi-randomized clinical trial. Gen Hosp Psychiatry. 2023 Sep-Oct;84:266-267. doi: 10.1016/j.genhosppsych.2023.06.009. Epub 2023 Jun 21. No abstract available.

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Juliette SALLES, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: In this study we aimed to investigated the impact of this intervention to prevent the PTSD in the relatives by comparing the PTSD prevalence in a group of relatives that loved ones were hospitalized after the confinement measure but before the OLAF intervention and a group of relatives that loved ones were hospitalized during the OLAF intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2020

First Posted

July 14, 2020

Study Start

June 12, 2020

Primary Completion

October 12, 2021

Study Completion

October 12, 2021

Last Updated

June 1, 2022

Record last verified: 2022-05

Locations